|
End-of-day quote
Thailand S.E.
2026-09-29
|
5-day change | 1st Jan Change | ||
| 9.000 THB | +0.56% |
|
+3.45% | - |
| 09:25am | AbbVie unveils promising results for its obesity drug candidate |  |
| 08:24am | Merck's experimental skin disease drug succeeds in mid-stage study | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
AbbVie Inc.(ABBV)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
AbbVie Inc.(ABBV)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
AbbVie Inc.(ABBV)
EBIT
Dividend / Share (DPS)
Data source:
AbbVie Inc.(ABBV)
Cash or Net Debt
- Stock Market
- Stocks
- ABBV Stock
- ABBV80 Stock
- Consensus AbbVie Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
